MetLife Target price 2025 - Analyst rating & recommendation
MetLife Classifications & Recommendation:
MetLife Price Target
| Target Price | $94.35 |
| Price | $82.07 |
| Potential |
14.96%
register free of charge
|
| Number of Estimates | 15 |
|
15 Analysts have issued a price target MetLife 2026 .
The average MetLife target price is $94.35.
This is
14.96%
register free of charge
$113.40
38.17%
register free of charge
$82.82
0.91%
register free of charge
|
|
| A rating was issued by 21 analysts: 16 Analysts recommend MetLife to buy, 5 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the MetLife stock has an average upside potential 2026 of
14.96%
register free of charge
|
Sales and Margin forecast 2025, 2026 to 2028
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Billion $ | 71.05 | 75.47 |
| 6.28% | 6.22% | |
| EBITDA Margin | 10.46% | 10.63% |
| 80.72% | 1.58% | |
| Net Margin | 5.95% | 7.72% |
| 188.14% | 29.79% |
10 Analysts have issued a sales forecast MetLife 2025 . The average MetLife sales estimate is
This results in the following potential growth metrics:
17 MetLife Analysts have issued a net profit forecast 2025. The average MetLife net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2028
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share $ | 5.94 | 8.74 |
| 228.18% | 47.14% | |
| P/E | 9.39 | |
| EV/Sales | 0.69 |
17 Analysts have issued a MetLife forecast for earnings per share. The average MetLife EPS is
This results in the following potential growth metrics and future valuations:
Current MetLife Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Piper Sandler |
Locked
➜
Locked
|
Locked | Sep 19 2025 |
| Wolfe Research |
Locked
➜
Locked
|
Locked | Sep 16 2025 |
| Morgan Stanley |
Locked
➜
Locked
|
Locked | Aug 18 2025 |
| Jefferies |
Locked
➜
Locked
|
Locked | Aug 11 2025 |
| Keefe, Bruyette & Woods |
Locked
➜
Locked
|
Locked | Aug 11 2025 |
| UBS |
Locked
➜
Locked
|
Locked | Aug 07 2025 |
| Morgan Stanley |
Locked
➜
Locked
|
Locked | Jul 14 2025 |
| Analyst Rating | Date |
|---|---|
|
Locked
Piper Sandler:
Locked
➜
Locked
|
Sep 19 2025 |
|
Locked
Wolfe Research:
Locked
➜
Locked
|
Sep 16 2025 |
|
Locked
Morgan Stanley:
Locked
➜
Locked
|
Aug 18 2025 |
|
Locked
Jefferies:
Locked
➜
Locked
|
Aug 11 2025 |
|
Locked
Keefe, Bruyette & Woods:
Locked
➜
Locked
|
Aug 11 2025 |
|
Locked
UBS:
Locked
➜
Locked
|
Aug 07 2025 |
|
Locked
Morgan Stanley:
Locked
➜
Locked
|
Jul 14 2025 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
